NXGL
NEXGEL, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$0.31
−8.66%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−5.0x
Market Cap
$3.02M
MomentumView details →
1D Return
−8.66%
YTD Return
−79.86%
RSI (14)
39.9
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−5.0x
Market Cap
$3.02M
RSI (14)
39.9
MomentumView details →
1D Return
−8.66%
YTD Return
−79.86%
SummaryUpdated Jun 1, 2026
NEXGEL, Inc. (NASDAQ:NXGL) is a specialty hydrogel manufacturer founded in 1997 and based in Langhorne, Pennsylvania. Originally known as AquaMed Technologies, Inc., the company changed its name to NEXGEL in November 2019 and went public in December 2021. The company specializes in manufacturing high water content, electron beam cross-linked aqueous polymer hydrogels that serve multiple industries including wound care, medical diagnostics, transdermal drug delivery, and cosmetics. Over the past few years, NEXGEL has transformed from a primarily contract manufacturing business into a diversified company with both manufacturing services and branded consumer products.
Similar companies
Latest newsMore news →
NexGel, Inc. appointed Kevin Harris as Chair of the Special Committee for Strategic Review and Value Creation, effective August 20, 2026.15d agoNEXGEL, Inc. formed a Special Committee for Strategic Review and Value Creation.15d agoNEXGEL, Inc. appointed Brian Kieser as Interim Chief Executive Officer.15d ago